Correlation between serum cytokeratin-18 and the progression or regression of non-alcoholic fatty liver disease



Título del documento: Correlation between serum cytokeratin-18 and the progression or regression of non-alcoholic fatty liver disease
Revue: Annals of hepatology
Base de datos: PERIÓDICA
Número de sistema: 000413457
ISSN: 1665-2681
Autores: 1
1
1
1
1
1
1
1
1
Instituciones: 1Kawasaki Medical School, Kawasaki Hospital, Okayama. Japón
Año:
Periodo: Nov-Dic
Volumen: 14
Número: 6
Paginación: 837-844
País: México
Idioma: Inglés
Tipo de documento: Artículo
Enfoque: Analítico, descriptivo
Resumen en inglés Diagnosis of non-alcoholic fatty liver disease (NAFLD) is limited by the need for liver biopsies. Serum cytokeratin 18 (CK-18) levels have been investigated as potential biomarkers for the presence of NAFLD and non-alcoholic steatohepatitis (NASH). Herein, we assessed the correlation between CK-18 levels and NAFLD progression. Material and methods. Serum CK-18 levels were estimated using the M30 antibody enzyme-linked immunosorbent assay in 147 patients diagnosed with NAFLD. In 72 patients, disease progression was evaluated by repeated liver biopsy, which was conducted after 4.3 ± 2.6 years. The relationship between the CK-18 levels and liver histological findings was assessed. Results. The CK-18 levels were useful for identifying NAFLD patients with NAFLD activity scores (NAS) ≥ 5 (NAS ≥ 5 vs. ≤ 4: 675.1 U/L vs. 348.7 U/L; p < 0.0001). A cut-off value of 375 U/L was calculated using the receiver operating characteristic curve approach, with a specificity and sensitivity of 81.5 and 65%, respectively, for the diagnosis of NASH. Among the 72 patients who underwent repeated liver biopsy, 11 patients with a progressed NAS also had significantly increased serum CK-18 levels (p < 0.01); in 30 patients with an improved NAS, there was a significant improvement in the mean CK-18 levels (p < 0.0001). The 31 patients with static NAS had static CK-18 levels. Conclusions. In conclusion, serum CK-18 levels can predict NAS ≥ 5 in NAFLD patients. In NAFLD patients, serum CK-18 levels reflect NAS values and correlate with histological changes, and they appear to be useful indicators of progression and improvement
Disciplinas: Medicina
Palabras clave: Diagnóstico,
Gastroenterología,
Hígado graso no alcohólico,
Indicadores pronósticos,
Citoqueratina 18,
Fibrosis hepática
Keyword: Medicine,
Diagnosis,
Gastroenterology,
Non alcoholic fatty liver,
Prognosis indicators,
Cytokeratin 18,
Liver fibrosis
Texte intégral: Texto completo (Ver PDF)